Accrete Pharmaceuticals manufactures and supplies Imatinib Intermediates in India as part of its pharmaceutical intermediate portfolio. The portfolio includes N-(5-Amino-2-Methyl Phenyl)-4-(3-Pyridyl)-2-Pyrimidine Amine with CAS No. 152460-10-1 and 4-(4-methyl piperazino methyl) benzoic acid dihydrochloride with CAS No. 106261-49-8 .
Incorporated in 2005, Accrete Pharmaceuticals Private Limited was established by a group of committed professionals with an initial focus on anti-cancer products. The company operates a cGMP pharmaceutical intermediate manufacturing facility near Hyderabad, Telangana, India, supporting its product manufacturing and supply activities.
Accrete Pharmaceuticals gives priority to quality product supply, proper documentation, customer satisfaction, and a clean manufacturing environment. The company follows established quality methodologies and scientifically derived technologies to support its pharmaceutical intermediate manufacturing activities.
Manufacturing activities are supported by documentation and quality procedures including equipment validation, process validation, standard operating procedures and other applicable records to meet customer requirements. The company serves pharmaceutical industry requirements in India and international markets.
Request Product InformationN-(5-Amino-2-Methyl Phenyl)-4-(3-Pyridyl)-2-Pyrimidine Amine
4-(4-methyl piperazino methyl) benzoic acid dihydrochloride
Accrete Pharmaceuticals offers Imatinib Intermediates identified by their specific chemical names and CAS numbers. The portfolio includes two products supplied as part of the company's pharmaceutical intermediate range for industry requirements.
Accrete Pharmaceuticals manufactures and supplies N-(5-Amino-2-Methyl Phenyl)-4-(3-Pyridyl)-2-Pyrimidine Amine identified by CAS No. 152460-10-1. This product forms part of the company's Imatinib Intermediate and pharmaceutical intermediate portfolio.
Enquire About This ProductAccrete Pharmaceuticals manufactures and supplies 4-(4-methyl piperazino methyl) benzoic acid dihydrochloride identified by CAS No. 106261-49-8. This product is included in the company's Imatinib Intermediate and pharmaceutical intermediate portfolio.
Enquire About This ProductAccrete Pharmaceuticals is a pharmaceutical intermediate manufacturer in India focused on quality-oriented manufacturing processes, established quality methodologies, and appropriate product documentation.
The company's manufacturing operations are supported by a cGMP facility near Hyderabad, Telangana, India. The facility supports the company's pharmaceutical intermediate portfolio, including its range of Imatinib Intermediates.
Accrete Pharmaceuticals places emphasis on quality product supply, proper documentation, customer requirements, and scientifically derived technologies across its manufacturing activities.
Discuss Your RequirementsEstablished quality methodologies are followed across pharmaceutical intermediate manufacturing activities.
Manufacturing operations are supported by a cGMP facility located near Hyderabad, Telangana, India.
Appropriate documentation supports product manufacturing and customer requirements.
Manufacturing and supply activities focus on customer requirements and product needs.
Contact Accrete Pharmaceuticals for enquiries related to Imatinib Intermediates and pharmaceutical intermediate requirements in India.
Discuss Your Product Requirements
Share your requirements with our team for product information and enquiry support.